Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma

193Citations
Citations of this article
150Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Chondrosarcoma is a heterogeneous collection of malignant bone tumors and is the second most common primary malignancy of bone after osteosarcoma. Recent work has identified frequent, recurrent mutations in IDH1 or IDH2 in nearly half of central chondrosarcomas. However, there has been little systematic genomic analysis of this tumor type, and, thus, the contribution of other genes is unclear. Here we report comprehensive genomic analyses of 49 individuals with chondrosarcoma (cases). We identified hypermutability of the major cartilage collagen gene COL2A1, with insertions, deletions and rearrangements identified in 37% of cases. The patterns of mutation were consistent with selection for variants likely to impair normal collagen biosynthesis. In addition, we identified mutations in IDH1 or IDH2 (59%), TP53 (20%), the RB1 pathway (33%) and Hedgehog signaling (18%). © 2013 Nature America, Inc. All rights reserved.

Cite

CITATION STYLE

APA

Tarpey, P. S., Behjati, S., Cooke, S. L., Van Loo, P., Wedge, D. C., Pillay, N., … Futreal, P. A. (2013). Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nature Genetics, 45(8), 923–926. https://doi.org/10.1038/ng.2668

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free